# Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours

> **NCT05478486** · PHASE1 · COMPLETED · sponsor: **Godavari Biorefineries Limited** · enrollment: 7 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** MSP008-22

## Key facts

- **NCT ID:** NCT05478486
- **Lead sponsor:** Godavari Biorefineries Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2026-01-23
- **Final completion:** 2026-01-23
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05478486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05478486, "Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05478486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*